ClassID:

20952

A61K38/185 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3

Recent Application in this class:
#1
20260144895
2026-05-28

ADJUSTABLE GENE THERAPY

#2
20260109997
2026-04-23

BDNF GENE THERAPY

#3
20260097099
2026-04-09

PAINLESS NGF FOR FRACTURE REPAIR

#4
20260053738
2026-02-26

USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS

#5
20260048006
2026-02-19

INTRANASAL ADMINISTRATION OF BDNF FOR THE TREATMENT OF SENSORINEURAL HEARING LOSS

#6
20260041733
2026-02-12

COMBINATION FOR USE IN OPHTHALMOLOGY

#7
20260027185
2026-01-29

COMPOSITION FOR PREVENTING OR TREATING HERNIATED INTERVERTEBRAL DISC OR PAIN CAUSED THEREBY, COMPRISING HYDROGEL PATCH

#8
20260027184
2026-01-29

METHODS AND DEVICES FOR PROMOTING NERVE GROWTH AND REGENERATION

#9
20260014096
2026-01-15

MEDICAL PATCH FOR CONTROLLED DELIVERY OF WOUND HEALING FACTORS AND THERAPIES

#10
20260007720
2026-01-08

TISSUE REGENERATIVE MULTI-DRUG COCKTAIL AND APPARATUS FOR DELIVERY THEREOF

#11
20250388697
2025-12-25

ANTI-SOD1 NANOBODIES

#12
20250367256
2025-12-04

METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH COMPRISING GDNF ADMINISTRATION

#13
20250367192
2025-12-04

BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME

#14
20250360168
2025-11-27

METHODS FOR MAKING HUMAN GROWTH FACTOR CONCENTRATE AND COMPOSITIONS AND USES THEREOF

#15
20250332220
2025-10-30

USE OF CEREBRAL DOPAMINE NEUROTROPHIC FACTOR FOR AMELIORATING PNEUMONIA

#16
20250332091
2025-10-30

COATINGS FOR BIOLOGICAL INTERFACE ON IMPLANTS

#17
20250276041
2025-09-04

COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES

#18
20250276038
2025-09-04

HISTATIN COMBINATIONS AND METHODS FOR TREATING OR INHIBITING CELL LOSS

#19
20250235492
2025-07-24

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING TEAR FILM COMPOSITION TO TREAT CORNEAL DEFECTS

#20
20250228970
2025-07-17

GENE THERAPY FOR THE TREATMENT OF COGNITIVE DISORDERS

#21
20250222072
2025-07-10

METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE

#22
20250205308
2025-06-26

Supraparticles

#23
20250195621
2025-06-19

SYNTHETIC PLATELETS

#24
20250170214
2025-05-29

METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH COMPRISING GDNF ADMINISTRATION

#25
20250135008
2025-05-01

ADHESIVE CELL TISSUE GELS

#26
20250120920
2025-04-17

DRUG-DELIVERING NERVE WRAP

#27
20250108006
2025-04-03

BIOACTIVE GRANULAR HYDROGEL SCAFFOLDS AND USE THEREOF

#28
20250075215
2025-03-06

COMPOSITIONS AND METHODS FOR MODULATING NEURONAL EXCITABILITY AND MOTOR BEHAVIOR

#29
20250073273
2025-03-06

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF INFLAMMATORY DISEASE OR PAIN, COMPRISING MESENCHYMAL STEM CELLS EXPRESSING PTX-3, TIMP1 AND BDNF AS ACTIVE INGREDIENT

#30
20250064776
2025-02-27

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS

#31
20250057760
2025-02-20

USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS

#32
20250051750
2025-02-13

AADC/GDNF POLYNUCLEOTIDE, AND USE THEREOF IN TREATING PARKINSON'S DISEASE

#33
20250049889
2025-02-13

NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF

#34
20250041235
2025-02-06

FUNCTIONALIZED BIOLOGICAL MEMBRANES WITH MODIFYING PROTEIN MOLECULES, AND METHODS OF MAKING AND USES THEREOF

#35
20250032581
2025-01-30

COMPOSITIONS AND ARTICLES COMPRISING AN ADNF POLYPEPTIDE

#36
20250032580
2025-01-30

USE OF ADNF POLYPEPTIDES IN THERAPY

#37
20250009846
2025-01-09

RECOMBINANT PROTEIN OF NERVE GROWTH FACTOR MUTANT AND USE THEREOF

#38
20250001004
2025-01-02

Methods and Compositions for Treating Conditions Involving the Eye

#39
20240424060
2024-12-26

NGF ISOFORM FOR USE IN THE TREATMENT OF OCULAR PATHOLOGIES

#40
20240424024
2024-12-26

PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES

#41
20240415976
2024-12-19

GPI ANCHORED PROTEINS AND EXTRACELLULAR VESICLES COMPRISING THEM

#42
20240415932
2024-12-19

Systems and Methods for Angiogenic Treatment in Wound Healing

#43
20240392316
2024-11-28

ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME

#44
20240382562
2024-11-21

METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS

#45
20240374694
2024-11-14

METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SPINAL CORD INJURY

#46
20240366724
2024-11-07

IMMUNOREGULATORY MOLECULES AND USES THEREFOR

#47
20240366723
2024-11-07

COMBINATION THERAPY FOR THE TREATMENT OF ENTERIC NEUROPATHIES

#48
20240358634
2024-10-31

AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS

#49
20240342308
2024-10-17

Methods and Compositions for Treating Conditions Involving the Eye

#50
20240325608
2024-10-03

DELIVERY SYSTEM AND METHOD FOR USING SAME

#51
20240325569
2024-10-03

Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of BDNF, VEGFA, BFGF, NGF, GDNF, NT3, CNTF, and IGF1 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-BDNF, or Escherichia coli strain SCS110-AF/VTvaf17-VEGFA, or Escherichia coli strain SCS110-AF/VTvaf17-BFGF, or Escherichia coli strain SCS110-AF/VTvaf17-NGF, or Escherichia coli str

#52
20240325548
2024-10-03

DYNAMIC BIOACTIVE SCAFFOLDS AND THERAPEUTIC USES THEREOF AFTER CNS INJURY

#53
20240285521
2024-08-29

USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS

#54
20240277808
2024-08-22

PAINLESS NGF FOR FRACTURE REPAIR

#55
20240270855
2024-08-15

NEURO-MESENCHYME UNITS CONTROL ILC2 AND OBESITY VIA A BRAIN-ADIPOSE CIRCUIT

#56
20240269343
2024-08-15

USE OF IMMUNE MODULATORS TO IMPROVE NERVE REGENERATION

#57
20240269237
2024-08-15

PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES

#58
20240262926
2024-08-08

Fusion Protein Containing BDNF

#59
20240261374
2024-08-08

PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES

#60
20240238375
2024-07-18

AAV VIRION ENCODING NEUROTROPHIC FACTOR AND USES THEREOF

#61
20240226236
2024-07-11

NERVE GROWTH FACTOR FUSION PROTEIN, PREPARATION METHOD AND USE THEREOF

#62
20240226109
2024-07-11

CO-THERAPY WITH VECTOR AND NICOTINIC AGONIST

#63
20240197829
2024-06-20

TREATMENT OF NEUROPATHIC CORNEAL PAIN WITH NGF

#64
20240181008
2024-06-06

METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH

#65
20240165203
2024-05-23

COMBINED TREATMENT OF BRAIN INJURY

#66
20240131114
2024-04-25

NERVE GROWTH FACTOR FUSION PROTEIN, PREPARATION METHOD AND USE THEREOF

#67
20240091311
2024-03-21

NGF ISOFORM FOR USE IN THE TREATMENT OF OCULAR PATHOLOGIES

#68
20240066099
2024-02-29

BDNF OTIC FORMULATIONS AND USE THEREOF

#69
20240024430
2024-01-25

Synthetic platelets

#70
20230404938
2023-12-21

Methods of treatment and prevention using 4-deoxy-L-erythro-5-hexoseulose uronic acid

#71
20230390156
2023-12-07

PHARMACEUTICAL PACKAGES COMPRISING POLYPROPYLENE CONTAINERS AND NGF AQUEOUS FORMULATIONS PACKAGED THEREIN

#72
20230363418
2023-11-16

COMPOSITION FOR PREVENTING OR TREATING NEUROPSYCHOLOGIC DISEASE, COMPRISING MANF

#73
20230355713
2023-11-09

PEPTIDE FOR THERAPEUTIC APPLICATIONS IN THE DERMATOLOGICAL FIELD

#74
20230330267
2023-10-19

NOVEL ENGINEERED CAPSID SEROTYPE OF RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR WITH ENHANCED TRANSDUCTION EFFICIENCY AND WIDESPREAD DISTRIBUTION IN THE BRAIN

#75
20230321155
2023-10-12

Use of Cell-Free Fat Extract for Treating Osteoporosis

#76
20230301994
2023-09-28

BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME

#77
20230285468
2023-09-14

EFFECTS OF CELL-FREE FAT LIQUID EXTRACT ON MACROPHAGE POLARIZATION MODULATION AND DISEASE TREATMENT

#78
20230265167
2023-08-24

COMPOSITIONS HAVING NEUROREGENERATIVE APPLICATIONS

#79
20230241169
2023-08-03

NERVE GROWTH FACTOR MUTANT

#80
20230226256
2023-07-20

NEW DRUG DELIVERY SYSTEM FOR OPHTALMIC USE

#81
20230190642
2023-06-22

GROWTH FACTOR OTIC FORMULATIONS

#82
20230135903
2023-05-04

Improved Supraparticles

#83
20230122991
2023-04-20

GROWTH FACTOR FORMULATION FOR CONDITION ASSOCIATED WITH OTIC EVENT

#84
20230114217
2023-04-13

METHODS OF TREATING EPIDERMOLYSIS BULLOSA WITH CELL-FREE AMNIOTIC FLUID COMPOSITIONS

#85
20230094423
2023-03-30

DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR

#86
20230086560
2023-03-23

Nerve Guidance Conduit Comprising Neural Crest Stem-Like Cells and/or Schwann Cell Precursor-Like Cells and Methods of Making and Using the Same

#87
20230075630
2023-03-09

EXTRACELLULAR VESICLE-BASED AGENTS AND METHODS FOR THE TREATMENT OF NEUROPATHIC DISORDERS

#88
20230022970
2023-01-26

USE OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) FOR THE TREATMENT OF ENTERIC NEUROPATHIES

#89
20220409669
2022-12-29

Nerve Xenografts and Related Methods

#90
20220401517
2022-12-22

AGENT FOR USE IN TREATMENT OR PREVENTION OF OPHTHALMIC DISORDERS

#91
20220395582
2022-12-15

COMPOSITIONS AND METHODS OF INDUCING DIFFERENTIATION OF A HAIR CELL

#92
20220395558
2022-12-15

COMPOSITIONS FOR TREATMENT OF ERECTILE DYSFUNCTION, METHODS FOR PREPARING THE SAME AND APPLICATIONS THEREOF

#93
20220387426
2022-12-08

BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME

#94
20220378932
2022-12-01

FUSION PROTEINS FOR DELIVERY OF GDNF TO THE CNS

#95
20220362337
2022-11-17

Method of treatment

#96
20220339254
2022-10-27

REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIES

#97
20220339251
2022-10-27

COMPOSITIONS AND METHODS FOR RECOMBINANT NERVE GROWTH FACTOR

#98
20220331403
2022-10-20

METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS

#99
20220249612
2022-08-11

COMPOSITIONS FOR TREATMENT OF AZOOSPERMIA, METHODS FOR PREPARING THE SAME AND APPLICATIONS THEREOF

#100
20220249575
2022-08-11

FORMULATION AND TREATMENT FOR OPHTHALMIC DISORDERS

#101
20220226543
2022-07-21

Patterned Hydrogel Devices and Methods for Neural Regeneration

#102
20220226435
2022-07-21

Ciliary Neurotrophic Factor Receptor Ligands and Methods of Using the Same

#103
20220202716
2022-06-30

EMPTY POROUS PARTICLES FOR USE IN TREATMENT, PREVENTION AND/OR POSTPONEMENT OF DEGENERATION OF NEURODEGENERATIVE DISEASES, NEURONS AND GLIA

#104
20220202705
2022-06-30

THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR NONINVASIVE OCULAR BIOLOGIC DELIVERY

#105
20220193087
2022-06-23

COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS

#106
20220184028
2022-06-16

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS

#107
20220175844
2022-06-09

Methods of treating optic nerve diseases using neural progenitor cell growth factors

#108
20220168228
2022-06-02

Supraparticle Formulations

#109
20220152152
2022-05-19

PAINLESS NGF FOR FRACTURE REPAIR

#110
20220135975
2022-05-05

INHIBITION OF LET7I AS A MEANS TO ENHANCE THE PROTECTIVE EFFECT OF PROGESTERONE AGAINST STROKE

#111
20220105136
2022-04-07

COMPOSITION AND METHODS OF AN ADVANCED THERAPY FOR NEURODEGENERATIVE DISEASES

#112
20220088139
2022-03-24

NERVE GROWTH FACTOR MUTANT

#113
20220088136
2022-03-24

NERVE GROWTH FACTOR MUTANT

#114
20220079935
2022-03-17

COMPOUNDS AND TREATMENTS THAT ENHANCE ENTERIC NERVOUS SYSTEM FUNCTION

#115
20220072098
2022-03-10

BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

#116
20220071897
2022-03-10

USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS

#117
20220062381
2022-03-03

Methods for promoting wound healing and hair growth comprising GDNF administration

#118
20220056478
2022-02-24

Adeno-associated virus vectors for treatment of Rett syndrome

#119
20220040096
2022-02-10

AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS

#120
20220040095
2022-02-10

Auris formulations for treating otic diseases and conditions

#121
20210395354
2021-12-23

Anti-human NGF antibodies and methods using same

#122
20210393787
2021-12-23

COMPOSITIONS AND METHODS FOR TREATING FRONTOTEMPORAL DEMENTIA

#123
20210317451
2021-10-14

Compositions and methods for modulating neuronal excitability and motor behavior

#124
20210309754
2021-10-07

Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody

#125
20210299218
2021-09-30

NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF

#126
20210275638
2021-09-09

Polyhedrin-based slow release growth factor system for neuroprotection of retinal ganglion cell neurons

#127
20210269531
2021-09-02

Anti-TrkB agonist antibodies binding to D1 domain of TrkB

#128
20210244768
2021-08-12

CELL COMPOSITIONS AND USES THEREOF

#129
20210244668
2021-08-12

Particles for delivery of proteins and peptides

#130
20210228495
2021-07-29

DRUG-LOADED TISSUE ADHESIVE FILM AND PREPARATION METHOD THEREFOR

#131
20210205234
2021-07-08

Sustained drug release sheet for treating nerve injury

#132
20210196830
2021-07-01

GLYPISOME AS AN ENHANCER OF ANGIOGENIC GROWTH FACTOR ACTIVITY

#133
20210196792
2021-07-01

Immunoregulatory molecules and uses therefor

#134
20210138039
2021-05-13

PAIN RESPONSE MEDIATOR COMPOSITIONS AND METHODS FOR MAKING AND USING SAME

#135
20210128687
2021-05-06

METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS

#136
20210128482
2021-05-06

CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY

#137
20210106651
2021-04-15

BIO-MIMETIC FORMULATION

#138
20210077579
2021-03-18

Method of effecting neuroprotection using soluble neuregulin isoforms

#139
20210052663
2021-02-25

Compositions and Methods for Treatment of Cardiovascular Disorders

#140
20210041455
2021-02-11

Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

#141
20210024955
2021-01-28

Methods and compositions for inducible expression of neurotrophic factors

#142
20210023264
2021-01-28

Use of immune modulators to improve nerve regeneration

#143
20210007974
2021-01-14

COATINGS FOR BIOLOGICAL INTERFACE ON IMPLANTS

#144
20210000972
2021-01-07

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

#145
20200397762
2020-12-24

METHODS AND COMPOSITIONS FOR DIAGNOSING, TREATING, AND MONITORING TREATMENT OF SHANK3 DEFICIENCY ASSOCIATED DISORDERS

#146
20200385477
2020-12-10

Gene combination capable of high-efficiency expression of recombinant human nerve growth factor

#147
20200384061
2020-12-10

Fusion protein including BDNF

#148
20200376040
2020-12-03

USE OF CEREBROLYSIN

#149
20200368332
2020-11-26

METHOD OF ENHANCING VIRAL-MEDIATED GENE DELIVERY

#150
20200353008
2020-11-12

COMPOSITIONS AND METHODS FOR TREATING NERVE INJURY

#151
20200339647
2020-10-29

INHIBITOR OF ASTROCYTE TNF ALPHA FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES

#152
20200331977
2020-10-22

Nerve growth factor fusion protein, preparation method and use thereof

#153
20200325493
2020-10-15

Adeno-associated virus virion for gene transfer to nervous system cells

#154
20200325249
2020-10-15

Visible light-curable water-soluble chitosan derivative, chitosan hydrogel, and preparation method therefor

#155
20200282019
2020-09-10

METHODS OF TREATING NEURODEGENERATIVE DISEASES

#156
20200277570
2020-09-03

Delivery method

#157
20200254113
2020-08-13

FUSION PROTEINS FOR DELIVERY OF GDNF TO THE CNS

#158
20200253865
2020-08-13

Supraparticles

#159
20200237873
2020-07-30

Systems and methods for angiogenic treatment in wound healing

#160
20200237868
2020-07-30

Methods of promoting corticospinal neuronal outgrowth in neuronal lesions using a pro-regenerative human osteopontin fragment

#161
20200237867
2020-07-30

METHODS AND DEVICES FOR PROMOTING NERVE GROWTH AND REGENERATION

#162
20200231942
2020-07-23

ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF

#163
20200230051
2020-07-23

Auris formulations for treating otic diseases and conditions

#164
20200216847
2020-07-09

Inhibition of LET7I as a means to enhance the protective effect of progesterone against stroke

#165
20200206314
2020-07-02

HSV vectors for delivery of NT3 and treatment of CIPN

#166
20200197487
2020-06-25

A TRIPLE-EFFECT COCKTAIL PRODUCED BY NEURAL STEM CELLS AS A NOVEL NEUROREPAIR THERAPY FOR CHRONIC STAGE CNS AUTOIMMUNITY

#167
20200197297
2020-06-25

Use of encapsulated cell therapy for treatment of ophthalmic disorders

#168
20200190201
2020-06-18

TRKB OR TRKC AGONIST COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC CONDITIONS

#169
20200188486
2020-06-18

Sucrose acetate isobutyrate-based compositions, methods and uses thereof

#170
20200188483
2020-06-18

Stromal derived factor 1 and its use in the prevention and treatment of erectile dysfunction

#171
20200188441
2020-06-18

METHODS AND COMPOSITIONS FOR REDUCING CORNEAL ENDOTHELIAL CELL LOSS

#172
20200172862
2020-06-04

METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS

#173
20200155647
2020-05-21

NEUROTROPHINS FOR USE IN THE TREATMENT OF HEARING LOSS

#174
20200147174
2020-05-14

METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH

#175
20200138860
2020-05-07

BLOOD SERUM FOR USE IN THE TREATMENT OF NEURODEGENERATIVE OPHTHALMOLOGICAL PATHOLOGIES

#176
20200121596
2020-04-23

Reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction

#177
20200108244
2020-04-09

Neuro-stem cell stimulation and growth enhancement with implantable nanodevice

#178
20200078366
2020-03-12

Combination therapies for the treatment of alzheimer's disease and related disorders

#179
20200046850
2020-02-13

Genetic Construct

#180
20200040360
2020-02-06

Genetic construct

#181
20200038484
2020-02-06

Bioconjugation Methods for Targeted in Situ Therapeutic Delivery

#182
20200030416
2020-01-30

Synthetic platelets

#183
20200017590
2020-01-16

Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke or glaucoma

#184
20200009369
2020-01-09

Neuro-stem cell stimulation and growth enhancement with implantable nanodevice

#185
20200009368
2020-01-09

Neuro-stem cell stimulation and growth enhancement with implantable nanodevice

#186
20200000879
2020-01-02

Method of treatment

#187
20190381137
2019-12-19

BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

#188
20190374606
2019-12-12

NEUROTROPHIN MUTANTS FOR TREATING HEARING LOSS AND OTHER OTIC DISORDERS

#189
20190365856
2019-12-05

Method of selecting agents for the treatment of pain using neuronal differentiation

#190
20190365819
2019-12-05

Compositions for biological systems and methods for preparing and using the same

#191
20190351022
2019-11-21

METHODS TO ENHANCE NERVE REGENERATION UTILIZING NEURAL STEM CELLS AND IL12P40

#192
20190328837
2019-10-31

Ciliary neurotrophic factor receptor ligands and methods of using the same

#193
20190321453
2019-10-24

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

#194
20190307848
2019-10-10

Method of effecting neuroprotection using soluble neuregulin isoforms

#195
20190307846
2019-10-10

METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH

#196
20190307678
2019-10-10

Auris formulations for treating OTIC diseases and conditions

#197
20190255152
2019-08-22

COMPOSITION FOR ALLEVIATING OR TREATING PAIN

#198
20190224277
2019-07-25

BIO-MIMETIC FORMULATION

#199
20190216895
2019-07-18

BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

#200
20190204340
2019-07-04

USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME

#201
20190201452
2019-07-04

Genetically modified muscle cells which express neurotrophic factors

#202
20190192629
2019-06-27

Compositions Comprising CDNF or MANF for use in the Intranasal Treatment of Central Nervous System Diseases

#203
20190192577
2019-06-27

Postpartum cells derived from placental tissue, and methods of making and using the same

#204
20190184015
2019-06-20

IRRADIATION TREATMENT OF NEUROLOGICAL SENSATIONS BY PHOTOABLATION

#205
20190153383
2019-05-23

Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell

#206
20190144858
2019-05-16

Compositions and methods for modulating neuronal excitability and motor behavior

#207
20190143095
2019-05-16

Neuro-stem cell stimulation and growth enhancement with implantable nanodevice

#208
20190142868
2019-05-16

METHODS OF TREATING DISEASES ASSOCIATED WITH ILC3 CELLS

#209
20190125691
2019-05-02

Encapsulation-free controlled protein release system

#210
20190117782
2019-04-25

CELLULARIZED HYDROGELS AND METHODS OF USING THE SAME

#211
20190111109
2019-04-18

Polyelectrolyte complexes for delivery of agents to the CNS

#212
20190105373
2019-04-11

Nerve growth factor mutant

#213
20190099365
2019-04-04

THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR NONINVASIVE OCULAR BIOLOGIC DELIVERY

#214
20190083415
2019-03-21

Sustained drug release sheet for treating nerve injury

#215
20190070223
2019-03-07

Selection Method Of Highly Active Stem Cell For Treatment Of Intraventricular Hemorrhage In Preterm Infant

#216
20190060465
2019-02-28

Adhesive cell tissue gels

#217
20190060402
2019-02-28

METHOD OF ENHANCING DOPAMINERGIC NEURONAL CELL GROWTH OR SURVIVAL WITH MANF

#218
20190054279
2019-02-21

SYSTEM AND METHOD FOR TREATMENT OF HEMORRHAGIC STROKE

#219
20190054151
2019-02-21

Synthetic platelets

#220
20190046692
2019-02-14

Methods and kits for guiding growth of cells or cell components and uses thereof in tissue repair

#221
20190022220
2019-01-24

LIGHT-ACTIVATED ANCHORING OF THERAPEUTIC FACTORS TO TISSUES

#222
20180360973
2018-12-20

PROTEIN CONJUGATE USING A FATTY ACID DERIVATIVE AND METHOD FOR PREPARATION THEREOF

#223
20180353621
2018-12-13

Genetic construct

#224
20180338999
2018-11-29

Soft tissue repair and regeneration using postpartum-derived cells and cell products

#225
20180333458
2018-11-22

Mesenchymal stem cells for the treatment of CNS diseases

#226
20180326009
2018-11-15

Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions

#227
20180325992
2018-11-15

MODULATION OF AXON DEGENERATION

#228
20180321255
2018-11-08

Soluble MANF in pancreatic beta-cell disorders

#229
20180318398
2018-11-08

METHODS AND COMPOSITIONS USING AMPK ACTIVATORS FOR PHARMACOLOGICAL PREVENTION OF CHRONIC PAIN

#230
20180318241
2018-11-08

TREATMENT OF NERVOUS SYSTEM DISORDERS USING THYROID HORMONE NEUTRAL DOSES OF RXR AGONISTS

#231
20180271985
2018-09-27

Neurotherapeutic nanoparticle compositions comprising leukemia inhibitory factor

#232
20180271950
2018-09-27

Use of full-length amelogenin for promoting nerve growth or regeneration

#233
20180264081
2018-09-20

THERAPEUTIC PROTEIN FORMULATIONS

#234
20180264044
2018-09-20

Compositions for biological systems and methods for preparing and using the same

#235
20180256683
2018-09-13

Methods for treating heart failure with a TRKB agonist

#236
20180250422
2018-09-06

METHODS OF TREATING NEURODEGENERATIVE DISORDERS

#237
20180243343
2018-08-30

METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PARKINSON'S DISEASE

#238
20180236031
2018-08-23

COMPOSITIONS AND METHODS FOR RECOMBINANT NERVE GROWTH FACTOR

#239
20180207293
2018-07-26

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

#240
20180200352
2018-07-19

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

#241
20180200350
2018-07-19

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

#242
20180177830
2018-06-28

Compositions and methods for treatment of cardiovascular disorders

#243
20180177791
2018-06-28

Combination therapies for the treatment of Alzheimer's disease and related disorders

#244
20180177790
2018-06-28

Combination therapies for the treatment of Alzheimer's disease and related disorders

#245
20180177789
2018-06-28

Combination therapies for the treatment of Alzheimer'S disease and related disorders

#246
20180177736
2018-06-28

Cell lines and their use in encapsulated cell biodelivery

#247
20180170995
2018-06-21

P75NTR binding protein-Fc fusion protein and methods of treating pain

#248
20180161436
2018-06-14

Nerve growth factor composition and powder injection

#249
20180155275
2018-06-07

(E)-3-(3,4-dihydroxyphenyl)-N-(prop-2-yn-1-yl)acrylamide for treatment of neurodegenerative diseases

#250
20180147241
2018-05-31

Compositions and methods for treatment of cardiovascular disorders

#251
20180140672
2018-05-24

ADMINISTRATION OF GROWTH FACTORS FOR THE TREATMENT OF CNS DISORDERS

#252
20180133373
2018-05-17

Neurotrophic factor carrier, method for producing the same, and method for regenerating a nerve using the same

#253
20180125896
2018-05-10

Compositions and Methods for Treatment of Cardiovascular Disorders

#254
20180117113
2018-05-03

Amidated Dopamine Neuron Stimulating Peptide Restoration of Mitochondrial Activity

#255
20180117090
2018-05-03

Isolated adipose-derived mesenchymal stem cells treated with angelica extract or butylidenephthalide, and wherein the cells have an increased mitochondrial membrane potential and a decreased level of IL-8, and methods for treating parkinson's disease

#256
20180110833
2018-04-26

NERVE GROWTH FACTOR COMPOSITION AND POWDER INJECTION

#257
20180104310
2018-04-19

Nerve growth factor composition and powder injection

#258
20180055766
2018-03-01

Use of encapsulated cell therapy for treatment of ophthalmic disorders

#259
20180051248
2018-02-22

Methods for differentiating pluripotent cells

#260
20180036385
2018-02-08

AAV-mediated gene therapy for RPGR X-linked retinal degeneration

#261
20180036376
2018-02-08

BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

#262
20180021406
2018-01-25

Methods for treating back or neck pain caused by NGF using a therapeutic agent comprising REN-1820, ALE-0540 and capsaicin

#263
20180021404
2018-01-25

METHODS AND COMPOSITIONS FOR TREATING GLAUCOMA

#264
20180015180
2018-01-18

SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF

#265
20180000897
2018-01-04

Method of treating pain using agents that promote neuronal differentiation

#266
20170354762
2017-12-14

Implantable medical devices having double walled microspheres

#267
20170348392
2017-12-07

SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES

#268
20170340706
2017-11-30

LOCALLY RELEASED GROWTH FACTORS TO MEDIATE MOTOR RECOVERY AFTER STROKE

#269
20170333526
2017-11-23

Therapeutic use of a growth factor, METRNL

#270
20170326183
2017-11-16

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#271
20170319669
2017-11-09

METHOD OF ENHANCING VIRAL-MEDIATED GENE DELIVERY

#272
20170298110
2017-10-19

DOPAMINERGIC NEURONAL SURVIVAL-PROMOTING FACTORS AND USES THEREOF

#273
20170252403
2017-09-07

METHODS AND COMPOSITIONS FOR TREATING RETINAL DISORDERS

#274
20170246216
2017-08-31

Human amniotic fluid preparation having long-term stability

#275
20170240611
2017-08-24

Modulation of the VPS10p-Domain Receptor Family for the Treatment of Mental and Behavioural Disorders

#276
20170239299
2017-08-24

Postpartum cells derived from placental tissue, and methods of making and using the same

#277
20170224776
2017-08-10

Methods to enhance nerve regeneration utilizing neural stem cells and IL12P40

#278
20170224740
2017-08-10

Methods for treating traumatic brain injury with amnion-derived cellular cytokine solution (ACCS) or amnion-derived multipotent progenitor (AMP) cells

#279
20170209539
2017-07-27

Therapeutic Treatment For Metabolic Syndrome, Type 2 Diabetes, Obesity, Or Prediabetes

#280
20170173182
2017-06-22

Composition for mRNA delivery

#281
20170173181
2017-06-22

Methods of treating neurodegenerative disorders

#282
20170166926
2017-06-15

Targeting peptides for directing adeno-associated viruses (AAVs)

#283
20170166864
2017-06-15

Postpartum cells derived from placental tissue, and methods of making and using the same

#284
20170166863
2017-06-15

Postpartum cells derived from placental tissue, and methods of making and using the same

#285
20170165200
2017-06-15

COMPOSITION OF LIPID-BASED NANOPARTICLES FOR SMALL MOLECULES AND MACROMOLECULES

#286
20170145382
2017-05-25

Method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients

#287
20170145066
2017-05-25

Splice variants of GDNF and uses thereof

#288
20170143794
2017-05-25

Treatment of hyperalgesia, spontaneous pain, and phantom pain

#289
20170143770
2017-05-25

Soft tissue repair and regeneration using postpartum-derived cells and cell products

#290
20170128525
2017-05-11

Administration of Angiocidin for the Treatment of Cancer

#291
20170119850
2017-05-04

Method for treating chemotherapy-induced male infertility

#292
20170106088
2017-04-20

MAGNETIC DIRECTED ALIGNMENT OF STEM CELL SCAFFOLDS FOR REGENERATION

#293
20170087213
2017-03-30

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors

#294
20170072015
2017-03-16

Method of administering MANF for the protection of sensory cells

#295
20170044504
2017-02-16

Adeno-associated virus virions with variant capsid and methods of use thereof

#296
20170043059
2017-02-16

Implantable medical devices having double walled microspheres

#297
20170035849
2017-02-09

Method of effecting neuroprotection using soluble Neuregulin isoforms

#298
20170028022
2017-02-02

Neurogenic brain-derived neurotrophic factor peptides

#299
20170007670
2017-01-12

Method of treating intraocular tissue pathologies with nerve growth factor

#300
20170000853
2017-01-05

WOUND HEALING COMPOSITION